Universal American Corp. Stock Rating Upgraded by TheStreet (UAM)
The analysts wrote, “Universal American (UAM) has been upgraded by TheStreet Ratings from sell to hold. The company’s strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins.”
Shares of Universal American Corp. (NYSE:UAM) traded down 0.60% on Friday, hitting $8.27. 223,144 shares of the company’s stock traded hands. Universal American Corp. has a 1-year low of $6.60 and a 1-year high of $11.13. The stock has a 50-day moving average of $7.65 and a 200-day moving average of $7.28. The company’s market cap is $715.7 million.
Universal American Corp. (NYSE:UAM) last posted its quarterly earnings results on Monday, May 5th. The company reported $0.06 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.07 by $0.01. The company had revenue of $512.70 million for the quarter, compared to the consensus estimate of $514.43 million. During the same quarter last year, the company posted $0.20 earnings per share. Universal American Corp.’s revenue was down 9.0% compared to the same quarter last year. Analysts expect that Universal American Corp. will post $0.20 EPS for the current fiscal year.
Separately, analysts at Zacks upgraded shares of Universal American Corp. from an “underperform” rating to a “neutral” rating in a research note on Wednesday, April 2nd. They now have a $7.30 price target on the stock. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of $9.20.
Universal American Corp., through its health insurance and managed care subsidiaries, primarily serves the growing Medicare population by providing Medicare Advantage products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.